Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Ushio

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Journal of Cardiology Cases|December 17, 2021
Salvage from hemodialysis via percutaneous transluminal renal artery stenting for a jeopardized solitary functioning kidney: A case reportTomomi Ueda, Hajime Aoki, Yusuke Ushio, et al.
Clinical and Experimental Nephrology|September 25, 2024
Association of hyperphosphatemia with renal prognosis in patients with autosomal dominant polycystic kidney diseaseKosaku Nitta, Hiroshi Kataoka, Shun Manabe, et al.
Clinical and Experimental Nephrology|April 29, 2026
Attribute-based cross-classification reveals sex- and age-specific prognostic impact of anemia in ADPKDKosaku Nitta, Hiroshi Kataoka, Yusuke Ushio, et al.
Kidney International Reports|September 13, 2021
Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKDShiho Makabe, Shun Manabe, Hiroshi Kataoka, et al.
BMC Nephrology|March 18, 2026
Clinical awareness and targeted manual urine microscopy enable diagnosis of a fabry disease family missed by routine urinalysisHaruka Kato, Takashi Yokoyama, Shun Manabe, et al.
Clinical and Experimental Nephrology|February 15, 2022
Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney diseaseTaro Akihisa, Hiroshi Kataoka, Shiho Makabe, et al.
Clinical and Experimental Nephrology|February 10, 2020
Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective studyYusuke Ushio, Hiroshi Kataoka, Masayo Sato, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 9, 2021
Interstitial lung disease occurring shortly after tocilizumab infusion in a patient with polyarticular juvenile idiopathic arthritis: a case reportKoichi Sugihara, Risa Wakiya, Hiromi Shimada, et al.
Kidney360|April 4, 2022
Dose-Dependent Effect of Tolvaptan on Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney DiseaseTaro Akihisa, Shun Manabe, Hiroshi Kataoka, et al.
Kidney Medicine|March 2, 2026
Complete Remission After Percutaneous Renal Artery Angioplasty for Focal Segmental Glomerulosclerosis due to Takayasu Disease: A Case ReportYusuke Ushio, Shun Manabe, Anna Nakai, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Journal of Cardiology Cases|December 17, 2021
Salvage from hemodialysis via percutaneous transluminal renal artery stenting for a jeopardized solitary functioning kidney: A case reportTomomi Ueda, Hajime Aoki, Yusuke Ushio, et al.
Clinical and Experimental Nephrology|September 25, 2024
Association of hyperphosphatemia with renal prognosis in patients with autosomal dominant polycystic kidney diseaseKosaku Nitta, Hiroshi Kataoka, Shun Manabe, et al.
Clinical and Experimental Nephrology|April 29, 2026
Attribute-based cross-classification reveals sex- and age-specific prognostic impact of anemia in ADPKDKosaku Nitta, Hiroshi Kataoka, Yusuke Ushio, et al.
Kidney International Reports|September 13, 2021
Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKDShiho Makabe, Shun Manabe, Hiroshi Kataoka, et al.
BMC Nephrology|March 18, 2026
Clinical awareness and targeted manual urine microscopy enable diagnosis of a fabry disease family missed by routine urinalysisHaruka Kato, Takashi Yokoyama, Shun Manabe, et al.
Clinical and Experimental Nephrology|February 15, 2022
Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney diseaseTaro Akihisa, Hiroshi Kataoka, Shiho Makabe, et al.
Clinical and Experimental Nephrology|February 10, 2020
Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective studyYusuke Ushio, Hiroshi Kataoka, Masayo Sato, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 9, 2021
Interstitial lung disease occurring shortly after tocilizumab infusion in a patient with polyarticular juvenile idiopathic arthritis: a case reportKoichi Sugihara, Risa Wakiya, Hiromi Shimada, et al.
Kidney360|April 4, 2022
Dose-Dependent Effect of Tolvaptan on Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney DiseaseTaro Akihisa, Shun Manabe, Hiroshi Kataoka, et al.
Kidney Medicine|March 2, 2026
Complete Remission After Percutaneous Renal Artery Angioplasty for Focal Segmental Glomerulosclerosis due to Takayasu Disease: A Case ReportYusuke Ushio, Shun Manabe, Anna Nakai, et al.
Pageof 5